OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 5

Data from combined, up to 2021-03-20.

Vaccinated at 2021-03-20 (%) Vaccinated at 2021-03-20 (n) Population Vaccinated at 2021-03-13 (%) Vaccinated in past week (%)
Overall - 59.7% 1,475,936 2,473,177 58.6% 1.1%
Sex Female 59.6% 751,415 1,261,750 58.6% 1.0%
Male 59.8% 724,521 1,211,427 58.7% 1.1%
Ethnicity White - British 62.4% 904,407 1,448,426 61.5% 1.0%
White - Irish 56.7% 8,848 15,617 55.8% 0.9%
White - Any other White background 44.0% 34,867 79,205 43.0% 1.1%
Mixed - White and Black Caribbean 42.2% 1,337 3,171 40.2% 2.0%
Mixed - White and Black African 41.7% 1,071 2,569 40.6% 1.1%
Mixed - White and Asian 53.4% 1,365 2,555 52.3% 1.1%
Mixed - Any other mixed background 47.2% 2,331 4,942 45.8% 1.4%
Asian or Asian British - Indian 53.6% 26,985 50,323 52.8% 0.8%
Asian or Asian British - Pakistani 47.0% 11,732 24,983 45.2% 1.8%
Asian or Asian British - Bangladeshi 54.9% 3,395 6,188 52.8% 2.0%
Asian or Asian British - Any other Asian background 49.4% 11,088 22,428 48.3% 1.2%
Black or Black British - Caribbean 39.4% 5,901 14,959 37.3% 2.1%
Black or Black British - African 40.0% 6,097 15,260 37.9% 2.1%
Black or Black British - Any other Black background 42.7% 1,554 3,640 41.2% 1.5%
Other ethnic groups - Chinese 48.5% 4,564 9,415 47.1% 1.3%
Other ethnic groups - Any other ethnic group 43.5% 5,768 13,265 42.2% 1.3%
Patients with any other ethnicity code 59.7% 195,139 326,963 58.6% 1.1%
Ethnicity not stated 58.7% 8,841 15,071 57.5% 1.2%
Ethnicity not recorded 58.1% 240,534 414,092 56.9% 1.1%
Ethnicity (broad categories) White 61.4% 948,136 1,543,255 60.4% 1.0%
Mixed 46.2% 6,125 13,258 44.7% 1.5%
South Asian 51.2% 53,221 103,936 50.0% 1.2%
Black 40.0% 13,559 33,873 38.0% 2.0%
Other 45.6% 10,346 22,680 44.3% 1.3%
Unknown 58.8% 444,528 756,140 57.7% 1.1%
Index of Multiple Deprivation 1 (most deprived) 54.1% 199,556 368,557 52.5% 1.7%
2 57.4% 254,016 442,575 56.1% 1.3%
3 59.9% 314,265 524,776 58.9% 1.0%
4 61.7% 340,242 551,684 60.8% 0.9%
5 (least deprived) 63.0% 355,383 564,004 62.3% 0.7%
Unknown 57.8% 12,460 21,560 57.0% 0.7%
Clinical Risk Groups Patients in Any Clinical Risk Group 60.3% 546,105 905,772 59.2% 1.1%
Patients with Immunosuppression 60.9% 22,981 37,744 60.0% 0.9%
Patients with CKD 60.7% 71,008 116,942 59.7% 1.0%
Patients who have Chronic Respiratory Disease 60.4% 58,387 96,677 59.3% 1.1%
Patients with Diabetes 59.6% 193,844 325,444 58.5% 1.1%
Patients with Chronic Liver disease 59.4% 43,722 73,640 58.3% 1.1%
Patients with CNS Disease (including Stroke/TIA) 61.4% 83,006 135,184 60.2% 1.2%
Patients with Chronic heart disease 60.9% 228,690 375,557 59.8% 1.0%
Patients with Asplenia or Dysfunction of the Spleen 62.3% 8,827 14,168 61.5% 0.8%
Patients with Wider Learning Disability 61.0% 3,542 5,810 57.6% 3.4%
Patients with Severe Mental Health 55.7% 13,230 23,737 53.6% 2.1%
Other Groups Patients with Morbid Obesity 60.2% 46,984 78,064 58.9% 1.3%
Patients who are pregnant 61.1% 154 252 61.1% 0.0%